PLoS ONE (Jan 2021)

Development and validation of a prognostic tool: Pulmonary embolism short-term clinical outcomes risk estimation (PE-SCORE)

  • Anthony J. Weekes,
  • Jaron D. Raper,
  • Kathryn Lupez,
  • Alyssa M. Thomas,
  • Carly A. Cox,
  • Dasia Esener,
  • Jeremy S. Boyd,
  • Jason T. Nomura,
  • Jillian Davison,
  • Patrick M. Ockerse,
  • Stephen Leech,
  • Jakea Johnson,
  • Eric Abrams,
  • Kathleen Murphy,
  • Christopher Kelly,
  • H. James Norton

Journal volume & issue
Vol. 16, no. 11

Abstract

Read online

Objective Develop and validate a prognostic model for clinical deterioration or death within days of pulmonary embolism (PE) diagnosis using point-of-care criteria. Methods We used prospective registry data from six emergency departments. The primary composite outcome was death or deterioration (respiratory failure, cardiac arrest, new dysrhythmia, sustained hypotension, and rescue reperfusion intervention) within 5 days. Candidate predictors included laboratory and imaging right ventricle (RV) assessments. The prognostic model was developed from 935 PE patients. Univariable analysis of 138 candidate variables was followed by penalized and standard logistic regression on 26 retained variables, and then tested with a validation database (N = 801). Results Logistic regression yielded a nine-variable model, then simplified to a nine-point tool (PE-SCORE): one point each for abnormal RV by echocardiography, abnormal RV by computed tomography, systolic blood pressure Conclusions PE-SCORE model identifies PE patients at low- and high-risk for deterioration and may help guide decisions about early outpatient management versus need for hospital-based monitoring.